Table 1.
Characteristics | Total No. | No. of Patients |
---|---|---|
Age (year) | 1097 | |
>50 | 331 | |
≤50 | 766 | |
Histological type | 1056 | |
Infiltrating ductal carcinoma | 784 | |
Infiltrating lobular carcinoma | 203 | |
Medullary carcinoma | 6 | |
Mucinous carcinoma | 17 | |
Other, specify | 46 | |
Clinical stage | 1073 | |
I | 183 | |
II | 621 | |
III | 249 | |
IV | 20 | |
T stage | 1094 | |
T1 | 281 | |
T2 | 635 | |
T3 | 138 | |
T4 | 40 | |
N stage | 1077 | |
N0 | 516 | |
N1 | 364 | |
N2 | 120 | |
N3 | 77 | |
Distant metastasis | 934 | |
M0 | 912 | |
M1 | 22 | |
ER status | 984 | |
Negative | 228 | |
Positive | 756 | |
PR status | 981 | |
Negative | 325 | |
Positive | 656 | |
Her-2 status | 687 | |
Negative | 532 | |
Positive | 155 | |
Classical molecular subtype | 719 | |
Luminal | 566 | |
Her-2 overexpression | 37 | |
TNBC | 116 |
Abbreviations: ER, estrogen receptor; PR, progesterone receptor; Her-2, human epidermal growth factor receptor-2; TNBC, triple-negative breast cancer.